LIU Fan,ZHAO Yu,PAN Xinyu, et al. Application of In Vivo Imaging Technique in the Early Detection of NK/T Cell Lymphoma [J]. Chinese General Practice, 2019, 22(30): 3689-3693. DOI: 10.12114/j.issn.1007-9572.2019.00.473.
刘凡,赵玉,潘新宇等. 活体成像技术在NK/T细胞淋巴瘤早期检测中的应用价值研究[J]. 中国全科医学, 2019, 22(30): 3689-3693. DOI: 10.12114/j.issn.1007-9572.2019.00.473.
[1]胡凯,王继军,景红梅,等.老年高危淋巴瘤化疗联合CIK细胞免疫治疗临床观察[J].中华肿瘤防治杂志,2016,23(2):96-100.DOI:10.16073/j.cnki.cjcpt.2016.02.011.
HU K,WANG J J,JING H M,et al.Clinical observation of chemotherapy combined with CIK cells immunotherapy for the elderly lymphoma patients at high risk[J].Chin J Cancer Prev Treat,2016,23(2):96-100.DOI:10.16073/j.cnki.cjcpt.2016.02.011.
[2]杨小芸,沈丽达,龙庭凤,等.1326例非霍奇金淋巴瘤临床病理特点分析[J].中华肿瘤防治杂志,2016,23(9):605-609.DOI:10.16073/j.cnki.cjcpt.2016.09.012.
YANG X Y,SHEN L D,LONG T F,et al.Analysis of clinicopathological features of 1326 cases of non-Hodgkin's lymphoma[J].Chinese Journal of Cancer Prevention and Treatment,2016,23(9):605-609.DOI:10.16073/j.cnki.cjcpt.2016.09.012.
[3]曾麟舒,冯晓莉.结外NK/T细胞淋巴瘤研究进展[J].肿瘤防治研究,2016,43(1):87-90.DOI:10.3971/j.issn.1000-8578.2016.01.019.
ZENG L S,FENG X L.Advances in extranodal NK/T cell lymphoma research[J].Cancer Research on Prevention and Treatment,2016,43(1):87-90.DOI:10.3971/j.issn.1000-8578.2016.01.019.
[4]俞罡,陈静桂.结外鼻型 NK /T 细胞淋巴瘤的研究进展[J].中国实验血液学杂志,2016,24(1):271-274.DOI:10.7534/j.issn.1009-2137.2016.01.052.
YU G,CHEN J G.Advances in extranodal nasal type NK/T cell lymphoma[J].Chinese Journal of Experimental Hematology,2016,24(1):271-274.DOI:10.7534/j.issn.1009-2137.2016.01.052.
[5]YU J B,ZUO Z,ZHANG W Y,et al.Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma,nasal type[J].Hum Pathol,2014,45(11):2255-2262.DOI:10.1016/j.humpath.2014.04.024.
[6]刘蕾,郭宏强,杨树军.结外NK/T细胞淋巴瘤敏感药物筛选[J].中华肿瘤防治杂志,2015,22(2):86-90.DOI:10.16073/j.cnki.cjcpt.2015.02.002.
LIU L,GUO H Q,YANG S J,et al.Screening of sensitive NK/T cell lymphoma extranodal tumors[J].Chinese Journal of Cancer Prevention,2015,22(2):86-90.DOI:10.16073/j.cnki.cjcpt.2015.02.002.
[7]袁英,臧立,岳智杰,等.74例淋巴母细胞淋巴瘤的临床特点及预后分析[J].肿瘤防治研究,2018,45(3):154-159.DOI:10.3971/j.issn.1000-8578.2018.17.0751.
YUAN Y,ZANG L,YUE Z J,et al.Clinical features and prognosis of 74 cases of lymphoblastic lymphoma[J].Cancer Research on Prevention and Treatment,2018,45(3):154-159.DOI:10.3971/j.issn.1000-8578.2018.17.0751.
[8]刘卫平,李甘地,刘永惠,等.鼻 NK / T 细胞淋巴瘤 15 年研究报道[J].临床与实验病理学杂志,2000,16(2):89-92.DOI:10.13315/j.cnki.cjcep.2000.02.001.
LIU W P,LI G D,LIU Y H,et al.Nasal NK / T cell lymphoma:a 15-year study report [J].Journal of Clinical and Experimental Pathology,2000,16(2):89-92.DOI:10.13315/j.cnki.cjcep.2000.02.001.
[9]YU J B,ZUO Z,TANG Y,et al.Extranodal nasal-type natural killer/T-cell lymphoma of the skin:a clinicopathologic study of 16 cases in China[J].Hum Pathol,2009,40(6):807-816.DOI:10.1016/j.humpath.2008.08.020.
[10]郭晓轶,刘菲,韩雪迪,等.分子影像引导肿瘤免疫治疗新进展[J].肿瘤防治研究,2018,45(1):47-51.DOI:10.3971/j.issn.1000-8578.2018.17.0971.
GUO X Y,LIU F,HAN X D,et al.Progress of molecular imaging-guided tumor immunotherapy[J].Cancer Res Prev Treat,2018,45(1):47-51.DOI:10.3971/j.issn.1000-8578.2018.17.0971.
[11]田捷,董迪,惠辉,等.光学分子影像关键技术及应用研究[J].科研信息化技术与应用,2016,7(2):48-65.DOI:10.11871/j.issn.1674-9480.2016.02.006.
TIAN J,DONG D,HUI H,et al.Research on key technologies and applications of optical molecular imaging[J].E-science Technology & Application,2016,7(2):48-65.DOI:10.11871/j.issn.1674-9480.2016.02.006.
[12]刘凡,孙蕾,于建渤.光学分子影像学技术在肿瘤中的应用进展[J].中国医学影像技术,2017,33(9):1417-1420.DOI:10.13929/j.1003-3289.201611145.
LIU F,SUN L,YU J B.Application of optical molecular imaging technology in tumors[J].Chinese Journal of Medical Imaging Technology,2017,33(9):1417-1420.DOI:10.13929/j.1003-3289.201611145
[13]LI Z R,HU X J,MAO J J,et al.Optimization of mesenchymal stem cells (MSCs) delivery dose and route in mice with acute liver injury by bioluminescence imaging[J].Mol Imaging Biol,2015,17(2):185-194.DOI:10.1007/s11307-014-0792-6.
[14]WEBER J,HABERKORN U,MIER W.Cancer stratification by molecular imaging[J].Int J Mol Sci,2015,16(3):4918-4946.DOI:10.3390/ijms16034918.
[15]BANNAS P,LENZ A,KUNICK V,et al.Molecular imaging of tumors with nanobodies and antibodies:timing and dosage are crucial factors for improved in vivo detection[J].Contrast Media Mol Imaging,2015,10(5):367-378.DOI:10.1002/cmmi.1637.
[16]靳志萌,王通,郝伟亮,等.舌癌移植瘤活体成像的特点及应用[J].口腔医学研究,2016,32(1):39-42.DOI:10.11839/kqyxzh.2016.01.010.
JIN Z M,WANG T,HAO W L,et al.Characteristic and application of transplanted tumor imaging of tongue cancer[J].J Oral Sci Res,2016,32(1):39-42.DOI:10.11839/kqyxzh.2016.01.010.
[17]任苑蓉,陈军,刘红雨,等.应用活体内生物发光技术对人高转移大细胞肺癌细胞株L9981成瘤性和转移性研究[J].中国肺癌杂志,2008,11(3):321-326.DOI:10.3779/j.issn.1009-3419.2008.03.012.
REN Y R,CHEN J,LIU H Y,et al.The study of the tumorigenidty and metastasis ability in human lung cancer cell line L9981 using in vivo imaging[J].Chin J Lung Cancer,2008,11(3):321-326.DOI:10.3779/j.issn.1009-3419.2008.03.012.
[18]FRENSTER J D,PLACANTONAKIS D G.Bioluminescent in vivo imaging of orthotopic glioblastoma xenografts in mice[J].Methods Mol Biol,2018,1741:191-198.DOI:10.1007/978-1-4939-7659-1_15.
[19]IMAMURA T,SAITOU T,KAWAKAMI R.In vivo optical imaging of cancer cell function and tumor microenvironment[J].Cancer Sci,2018,109(4):912-918.DOI:10.1111/cas.13544.